Advanced Search

Home > Journals > Minerva Pediatrica > Past Issues > Minerva Pediatrica 2010 February;62(1) > Minerva Pediatrica 2010 February;62(1):51-5



A Journal on Pediatrics, Neonatology, Adolescent Medicine,
Child and Adolescent Psychiatry

Indexed/Abstracted in: CAB, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 0,532

Frequency: Bi-Monthly

ISSN 0026-4946

Online ISSN 1827-1715


Minerva Pediatrica 2010 February;62(1):51-5


Lack of improvement in the modality of b2 administration in pediatric departments: survey in Piedmont and Aosta Valley

Guala A. 1, Bertone A. 2, Barbaglia M. 1, Orioli L. 1, Boscardini L. 1, Rallo M. 1, Bignamini E. 3

1 Pediatric Department, Castelli Hospital, Verbania, Italy;
2 Pediatric Department, SS Pietro e Paolo Hospital Borgosesia, Vercelli, Italy;
3 Pneumology Unit, Regina Margherita Pediatric Hospital, Turin, Italy

AIM: In recent years many consensus conferences of scientific societies have reaffirmed the advantages of metered dose inhalator (MDI) and spacer administration compared to classic aerosol in acute asthma and maintenance therapy. Faced with a more than convincing documentation, the practitioners have shown a controversial attitude concerning this type of administration. At the same time, as a general acceptance of its superiority there is an inexplicable lack of use.
METHODS: This survey was carried out in 2006 and it involved pediatric hospital wards in Piedmont and Aosta Valley to evaluate the use of spacers in acute asthma in hospitalised children undergoing treatment. These results were compared to those obtained from another survey carried out in 2008 using identical questionnaires in the same departments in order to evaluate the implementation of such a practice.
RESULTS: In the two years between one survey and the other no increase in the use of MDI and spacer has been detected, but, on the contrary, a consistent decrease.
CONCLUSION: Notwithstanding the amount of evidence concerning its superiority compared to nebulisers MDI and spacer is not commonly used for asthma therapy yet. A “promotional” multidisciplinary intervention could play a determining role in the implementation of such a practice.

language: English


top of page